Your browser doesn't support javascript.
loading
Outcomes of persons with coronavirus disease 2019 in hospitals with and without standard treatment with (hydroxy)chloroquine.
Peters, Edgar Jg; Collard, Didier; Van Assen, Sander; Beudel, Martijn; Bomers, Marije K; Buijs, Jacqueline; De Haan, Lianne R; De Ruijter, Wouter; Douma, Renée A; Elbers, Paul Wg; Goorhuis, Abraham; Gritters van den Oever, Niels C; Knarren, Lieve Ghh; Moeniralam, Hazra S; Mostard, Remy Lm; Quanjel, Marian Jr; Reidinga, Auke C; Renckens, Roos; Van Den Bergh, Joop Pw; Vlasveld, Imro N; Sikkens, Jonne J.
Afiliação
  • Peters EJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Infectious Diseases, Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands. Electronic address: e.peters@amsterdamumc.nl.
  • Collard D; Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Van Assen S; Treant Zorggroep, Department of Internal Medicine/Infectious Diseases, Emmen, the Netherlands.
  • Beudel M; Amsterdam UMC, University of Amsterdam, Department of Neurology, Amsterdam Neuroscience Institute, Amsterdam, the Netherlands.
  • Bomers MK; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Infectious Diseases, Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.
  • Buijs J; Zuyderland Medical Center, Department of Internal Medicine, Heerlen/Sittard, the Netherlands.
  • De Haan LR; Flevoziekenhuis, Department of Internal Medicine, Almere, the Netherlands.
  • De Ruijter W; Noordwest Ziekenhuisgroep, Intensive Care Unit, Alkmaar, the Netherlands.
  • Douma RA; Flevoziekenhuis, Department of Internal Medicine, Almere, the Netherlands.
  • Elbers PW; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Intensive Care Medicine, Amsterdam Medical Data Science, Amsterdam Cardiovascular Sciences, Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.
  • Goorhuis A; Amsterdam UMC, University of Amsterdam, Department of Infectious Diseases, Amsterdam, the Netherlands.
  • Gritters van den Oever NC; Treant Zorggroep, Intensive Care Unit, Emmen, the Netherlands.
  • Knarren LG; Viecuri MC Noord-Limburg, Department of Internal Medicine, Venlo, the Netherlands.
  • Moeniralam HS; St Antonius Ziekenhuis, Department of Internal Medicine and Intensive Care Unit, Nieuwegein, the Netherlands.
  • Mostard RL; Zuyderland Medical Center, Department of Pulmonology, Heerlen/Sittard, the Netherlands.
  • Quanjel MJ; St Antonius Ziekenhuis, Department of Pulmonology, Nieuwegein, the Netherlands.
  • Reidinga AC; Martini Hospital, Intensive Care Unit, Groningen, the Netherlands.
  • Renckens R; Noordwest Ziekenhuisgroep, Department of Internal Medicine, Alkmaar, the Netherlands.
  • Van Den Bergh JP; Viecuri MC Noord-Limburg, Department of Internal Medicine, Venlo, the Netherlands.
  • Vlasveld IN; Martini Hospital, Intensive Care Unit, Groningen, the Netherlands; Martini Hospital, Department of Internal Medicine, Groningen, the Netherlands.
  • Sikkens JJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Infectious Diseases, Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.
Clin Microbiol Infect ; 27(2): 264-268, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33068758

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cloroquina / Tratamento Farmacológico da COVID-19 / Hospitais Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cloroquina / Tratamento Farmacológico da COVID-19 / Hospitais Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article